Unusual Facts
Oura's Acquisition Raises Questions
Single source · unconfirmed
Prepared by the Prisma AI-based automated newsroom · cross-checked against sources
Oura's acquisition of a health tech startup has raised conflict-of-interest questions for Eli Lilly, according to experts. The new deal, announced this week, is expected to grow the relationship between Eli Lilly and a telehealth company that markets GLP-1s. This may lead to more complicated relationships between the companies.
Sources: STAT News
🖼 AI illustration
Sources: STAT News
🖼 AI illustration
Prism: who is reporting · 1
Europe & USSTAT News
⚑ Spotted an error?
✓ Thank you! The editors will check within 24 hours.